MT
Matinas BioPharma Holdings, Inc.
MTNB · AMEX
$0.16 -15.83% (-$0.03)
1M -27.99%
Market Cap $1.04M
P/E Ratio -
Div. Yield -
ROE 181.46%
Bulios Fair Price
$0.22
36.1% upside
Trenutna cena
$0.16
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MTNB trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.58x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 49.10%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 323.22%
ROE 181.46%
ROA 214.22%
Debt
76 /100
Low Debt/Equity 0.00x
Current ratio 0.85x
Int. coverage N/A
Stability
13 /100
Unstable Beta 1.70x
EPS volatility 68.38%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MTNB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jerome D. Jabbour
Employees
2
Headquarters
Bedminster
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report